Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarks & Spencer Regulatory News (MKS)

Share Price Information for Marks & Spencer (MKS)

Share Price is delayed by 15 minutes
Get Live Data
361.60    3.20 (0.89%)
Bid:
360.90
Ask:
361.10
Spread: 0.20 (0.055%)
Market Cap: £7.43b
MKS Live PriceLast checked at - London Stock Exchange

Intraday Marks & Spencer Share Chart

Director/PDMR Shareholding

24 Jun 2016 11:53

RNS Number : 2317C
Marks & Spencer Group PLC
24 June 2016
 

Marks and Spencer Group Plc (the 'Company') Notification of Transactions of Directors/Persons Discharging Managerial Responsibility

 

Deferred Share Bonus Plan - 2015/16 award

It was confirmed on 24 June 2016 that on 22 June 2016 the following awards under the Marks and Spencer Group Deferred Share Bonus Plan were made to the following PDMRs of the Company:

 

Name of Participant

Value of Grant

Form of Award(Nil Cost Option /Conditional Award)

Maximum Number of Options / Shares

Steve Rowe

£115,195

Nil Cost Option

32,376

Patrick Bousquet-Chavanne

£182,910

Conditional Award

51,408

Laura Wade-Gery

£103,745

Nil Cost Option

29,158

Helen Weir

£309,750

Nil Cost Option

87,057

 

Note: The above awards were made under the Company's Annual Bonus Scheme for 2015/16. This required executive directors to defer 50% of their bonus earned into shares in the Deferred Share Bonus Plan. This award was granted as a nil cost option, where a participant will normally be entitled to exercise their award and receive free shares between the third and tenth anniversary of grant 2. There will be no match paid against these deferred shares, although the value of dividends accrued, in the form of dividend equivalents will be paid at the end of the period (third anniversary). No price is payable on the exercise of the award. For the purposes of this calculation, the grant was made at a share price of £3.558

 

The Annual Bonus Scheme is designed to focus and reward executives for specific operational improvements which will drive the Company's performance. The targets for the Company are determined annually by the Remuneration Committee and for 2015/16 incorporated a mixture of group profit before tax, corporate financial measures and individual performance.

 

2 Patrick Bosquet-Chavanne award is structured as conditional shares which vest on the third anniversary of grant.

 

3. Shareholdings of PDMRs

Directors

Total Holding of Ordinary Shares

Total Percentage Holding in the Company

Steve Rowe

188,535

De minimis

Patrick Bousquet-Chavanne

99,070

De minimis

Laura Wade-Gery

172,955

De minimis

Helen Weir

25,000

De minimis

 

The above holdings are at 24 June 2016, being the date of this announcement, and include holdings for Connected Persons.

The above information has been disclosed under DTR 3.1.4

 

For Queries please contact:

Corporate PR +44 (0)20 8718 1919

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHBZLFLQQFEBBF
Date   Source Headline
1st Jun 202610:00 amRNSAnnual Financial Report
1st Jun 20269:00 amRNSIssue of Shares and Total Voting Rights
28th May 20264:23 pmRNSLichfield Fulfilment Centre Disposal Completion
28th May 20262:12 pmRNSDirector/PDMR Shareholding
22nd May 20262:00 pmRNSDirector/PDMR Shareholding
20th May 202610:30 amRNSDirectorate change
20th May 20267:00 amRNSFinal Results
1st May 20269:00 amRNSIssue of Shares and Total Voting Rights
28th Apr 20262:57 pmRNSDirector/PDMR Shareholding
28th Apr 202610:40 amRNSHolding(s) in Company
1st Apr 20269:00 amRNSIssue of Shares and Total Voting Rights
30th Mar 20262:07 pmRNSDirector/PDMR Shareholding
24th Mar 202610:35 amRNSDirector/PDMR Shareholding
2nd Mar 20263:00 pmRNSDirector/PDMR Shareholding
2nd Mar 20261:00 pmRNSIssue of Shares and Total Voting Rights
19th Feb 20269:38 amRNSHolding(s) in Company
17th Feb 20263:23 pmRNSDirector/PDMR Shareholding
5th Feb 202611:48 amRNSDirector Declaration
3rd Feb 20269:57 amRNSDirector/PDMR Shareholding
2nd Feb 20269:00 amRNSTotal Voting Rights
29th Jan 202610:18 amRNSHolding(s) in Company
28th Jan 202610:42 amRNSDirector/PDMR Shareholding
12th Jan 20264:38 pmRNSDirector/PDMR Shareholding
8th Jan 20267:00 amRNSChristmas Trading Results
2nd Jan 20269:00 amRNSTotal Voting Rights
2nd Jan 20269:00 amRNSBlock listing Interim Review
30th Dec 202512:40 pmRNSDirector/PDMR Shareholding
30th Dec 202512:40 pmRNSDirector/PDMR Shareholding
11th Dec 202510:00 amRNS2025 PSP Award Targets
10th Dec 202510:39 amRNSDirector/PDMR Shareholding
3rd Dec 20254:19 pmRNSDirector/PDMR Shareholding
3rd Dec 20251:43 pmRNSDirector/PDMR Shareholding
1st Dec 20255:34 pmRNSDirector/PDMR Shareholding
1st Dec 20259:00 amRNSTotal Voting Rights
28th Nov 202512:55 pmRNSDirector/PDMR Shareholding
17th Nov 20259:00 amRNSDirectorate change
12th Nov 20255:11 pmRNSDirector/PDMR Shareholding
12th Nov 20259:00 amRNSDirectorate change
11th Nov 202512:00 pmRNSInvestor Presentation
5th Nov 20257:00 amRNSHalf-year Financial Report
3rd Nov 20259:00 amRNSTotal Voting Rights
30th Oct 202510:00 amRNSDirectorate Change
28th Oct 20254:56 pmRNSDirector/PDMR Shareholding
14th Oct 202510:00 amRNSMarks and Spencer Chairmanship
1st Oct 20259:00 amRNSTotal Voting Rights
30th Sep 202511:36 amRNSDirector/PDMR Shareholding
1st Sep 20259:00 amRNSTotal Voting Rights
28th Aug 20252:23 pmRNSDirector/PDMR Shareholding
20th Aug 20259:30 amRNSDirectorate Change
1st Aug 20259:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.